Paper76512
Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.
Gormley PE and 2 others. Cancer Res, 1978. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases. Papers, record 76512. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76512
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acridines | Major topic |
| DNA | Major topic |
| DNA-Directed RNA Polymerases | Major topic |
| Nucleic Acid Synthesis Inhibitors | Major topic |
| Reverse Transcriptase Inhibitors | Major topic |
| Animals | |
| Base Sequence | |
| Binding Sites | |
| Cell Survival | |
| Cells, Cultured | |
| Leukemia L1210 | |
| Nucleic Acid Denaturation | |
| Phenylenediamines | |
| Spectrometry, Fluorescence | |
| Temperature |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15977964 | Cardiotoxicity of cancer chemotherapy: implications for children. | Paediatr Drugs | 2005 | https://conductscience.org/library/papers/15977964 | PubMed |
| 6896455 | Clonal variation in the sensitivity of B16 melanoma to m-AMSA. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6896455 | PubMed |
| 6895696 | A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6895696 | PubMed |
| 6893934 | Enhanced killing of mammalian cells by radiation combined with m-AMSA. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6893934 | PubMed |
| 6548984 | m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6548984 | PubMed |
| 6174949 | Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids. | Nucleic Acids Res | 1981 | https://conductscience.org/library/papers/6174949 | PubMed |
| 3838469 | Design of a new DNA-polyintercalating drug, a bisacridinyl peptidic analogue of Triostin A. | Biochem J | 1985 | https://conductscience.org/library/papers/3838469 | PubMed |
| 3755785 | The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivo. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3755785 | PubMed |
| 393427 | m-AMSA and PALA: two new agents in cancer chemotherapy. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/393427 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/76512
GET https://conductscience.org/api/papers/v1/76512/authors